Morgan Stanley’s Amryt Pharma plc American Depositary Shares AMYT Stock Holding History

Morgan Stanley’s Portfolio AMYT Stock Details AMYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2,504,939	Closed	-$36.5M	–	7826
2023 Q1	$36.5M	Buy	2,504,939 +2,421,783	+2,912%	+$34.2M	﹤0.01%	1838
2022 Q4	$607K	Sell	83,156 -4,240	-5%	-$29.9K	﹤0.01%	5140
2022 Q3	$605K	Buy	87,396 +861	+1%	+$6.42K	﹤0.01%	5170
2022 Q2	$605K	Buy	86,535 +7,018	+9%	+$54.7K	﹤0.01%	5323
2022 Q1	$658K	Buy	79,517 +57,325	+258%	+$517K	﹤0.01%	5240
2021 Q4	$240K	Buy	22,192 +17,761	+401%	+$192K	﹤0.01%	5971
2021 Q3	$53K	Buy	4,431 +1,306	+42%	+$14.7K	﹤0.01%	6699
2021 Q2	$38K	Buy	3,125 +3,049	+4,012%	+$37.8K	﹤0.01%	6783
2021 Q1	$1K	Buy	+76	New	+$1.06K	﹤0.01%	7419

Morgan Stanley's AMYT Position: Q2 2023 in Review

Morgan Stanley sold out of Amryt Pharma plc American Depositary Shares (AMYT) in Q2 2023, closing a stake of 2,504,939 shares — an estimated $36.5M sold.

Morgan Stanley first reported a position in AMYT in Q1 2021 and held it in 9 quarters. The position peaked at $36.5M in Q1 2023. 0 funds tracked by Wall St. Rank hold AMYT as of Q2 2023.

Morgan Stanley reported no remaining Amryt Pharma plc American Depositary Shares position as of Q2 2023 after selling out during the quarter.
Morgan Stanley sold 2,504,939 Amryt Pharma plc American Depositary Shares shares in Q2 2023, an estimated $36.5M.
Morgan Stanley first reported a position in Amryt Pharma plc American Depositary Shares in Q1 2021 and held it in 9 quarters.
Morgan Stanley's Amryt Pharma plc American Depositary Shares position peaked at $36.5M in Q1 2023.
0 funds tracked by Wall St. Rank held Amryt Pharma plc American Depositary Shares as of Q2 2023.

Based on Morgan Stanley's 13F filing for Q2 2023, filed 14 Aug 2023.